The average 30-year fixed rate for a conforming loan rose 19 basis points to 3.52% last week, the Mortgage Bankers Association said Wednesday, the highest since March of 2020. U.S. mortgage rates jumped to the Read more…
The Australian dollar is almost unchanged on Wednesday as it trades just above the 0.72 level. On Tuesday, the Aussie posted strong gains of 0.51%, its best daily performance in a week. This was courtesy Read more…
As the debate over returning to the office rages, Americans have decided: They are staying put in their basements and bedrooms and at their kitchen tables. While the debate over when white-collar workers should return Read more…
Wall Street looks set for a cautious open ahead of key December CPI data that could indicate the fastest inflation rates since 1982. Dow futures nudge higher ahead of December inflation dataHeadline inflation could pass Read more…
BMO Capital analyst Gerrick Johnson says Take-Two’s $12.7 billion takeover of Farmville maker Zynga will allow it to expand its key game offerings in the fast-growing mobile sector. Take-Two Interactive (TTWO) – Get Take-Two Interactive Read more…
Chips slip to start year, but driving forces for industry remain well entrenched. The benchmark PHLX Semiconductor Index (SOX) is in retreat in early 2022, down about 2% through January 11. The index is still Read more…
The Euro trading at the upper side of the near-term range in European trading on Wednesday, after eventually penetrating into thick and falling daily Ichimoku cloud on Tuesday. The action is still holding below pivotal Read more…
Facebook must face the government’s monopoly lawsuit that alleges it has abused its social media dominance to stifle competition, a judge has ruled. Facebook now known as Meta Platforms (FB) – Get Meta Platforms Inc. Read more…
The U.S. Centers for Medicare and Medicaid Services said it will only cover treatment with Aduhelm, Biogen’s Alzheimer’s treatment, if patients are enrolled in a clinical trial. Biogen (BIIB) – Get Biogen Inc. Report shares slumped Read more…
Big names are overcoming supply problems, but concerns continue Real Money’s Kevin Curran says. Retail stocks have come a long way since the early days of the pandemic, with numerous brand names attracting investor interest Read more…